West Virginia HB4196: To offer long-acting reversible contraception to patients receiving methadone and suboxone at the treatment facility for the methadone and suboxone

What the bill says

An act to amend and reenact §16B-13-5 of the Code of West Virginia, 1931, as amended, relating to establishing reversible contraception to patients; and establishing parameters of how to offer long-acting reversible contraception. ARTICLE 13. MEDICATION-ASSISTED TREATMENT PROGRAM LICENSING ACT. §16B-13-5. Operational requirements. (a) The medication-assisted treatment program shall be licensed and registered in this state with the director, the Secretary of State, the State Tax Department, and all other applicable business or licensing entities. (b) The program sponsor need not be a licensed p.

From the enrolled text, February 20, 2026:

AN ACT to amend and reenact §16B-13-5 of the Code of West Virginia, 1931, as amended, relating to establishing reversible contraception to patients; and establishing parameters of how to offer long-acting reversible contraception. ARTICLE 13. MEDICATION-ASSISTED TREATMENT PROGRAM LICENSING ACT. §16B-13-5. Operational requirements. (a) The medication-assisted treatment program shall be licensed and registered in this state with the director, the Secretary of State, the State Tax Department, and all other applicable business or licensing entities. (b) The program sponsor need not be a licensed physician but shall employ a licensed physician for the position of medical director when required by the rules promulgated pursuant to this article. (c) Each medication-assisted treatment program shall designate a medical director. If the medication-assisted treatment program is accredited by a Substance Abuse and Mental Health Services Administration-approved accrediting body that meets nationally accepted standards for providing medication-assisted treatment, including the Commission on Accreditation of Rehabilitation Facilities or the Joint Commission on Accreditation of Healthcare Organizations, then the program may designate a medical director to oversee all facilities associated with the accredited medication-assisted treatment program. The medical director shall be responsible for the operation of the medication-assisted treatment program, as further specified in the rules promulgated pursuant to this article. He or she may delegate the day-to-day operation of a medication-assisted treatment program as provided …